ON THE ISSUE OF COMMON MENTAL HEALTH DISORDERS IN ADOLESCENTS WITH ONCOLOGICAL DISEASES DURING TREATMENT AND REMISSION

This article presents the results of a long-term study on mental health disorders in яadolescent patients with oncological and hematological diseases during stages of active antitumor treatment and remission (recovery). It was found that non-psychotic mental disorders prevail both during treatment and throughout the remission period. Adaptation disorders are most common during hospitalization, while residual organic syndromes of varying severity are more typical during remission. The study revealed that mood disorders predominantly reactive in nature prevail during active antitumor treatment. Psychogenic depression in adolescents is mainly represented by asthenic forms, with less frequent anxious and anxious-hypochondriacal variants. Upon completion of specific antitumor treatment, a residual non-psychotic organic disorder was identified, characterized in most patients by mild organic insufficiency symptoms: headaches triggered by physical and mental strain; vestibulopathy, resulting in dizziness and poor tolerance for travel; dysfunction of the brain's autonomic centers, manifesting as impaired thermoregulation, poor tolerance to heat and stuffiness; weather sensitivity; emotional lability; and impulsive emotional expression.